Search bioRxiv⌕ Search

Biology subjects

Kiyota, Y.

Publications and source records attributed to Kiyota, Y..

2 recordsLinked to original sources

Compounds toxic to stationary-phase yeast reveal a role for lipid metabolism in quiescent cell survival

The mechanisms that enable quiescent cells to survive nutrient-limited conditions remain imcompletely understood. To investigate these mechanisms, we performed a large-scale chemical screen to identify compounds that reduce viability of stationary-phase fission yeast cells. We identified two structurally related compounds that impair quiescent cell survival. In stationary phase, these compounds inhibited cell cycle re-entry, altered lipid droplets (LDs), and affected nuclear and chromosomal size, all of which are associated with lipid metabolism. In proliferating cells, they induced cell cycle arrest accompanied by nucleolar accumulation of cyclin-dependent kinase (CDK), a hallmark of stationary-phase cells, and inhibited mitochondrial oxygen consumption. The lipid synthesis inhibitor cerulenin similarly inhibited cell cycle re-entry and induced cell cycle arrest with nucleolar CDK accumulation; however, it did not reduce viability in stationary-phase cells or reproduce the other cellular effects. These results indicate that the compounds may affect lipid metabolism potentially by impairing lipid mobilization. Furthermore, the compounds were also toxic to stationary-phase budding yeast, suggesting conservation of survival mechanisms in quiescent cells. Together, our findings suggest that lipid metabolism, possibly lipid mobilization, plays a critical role in quiescent cell survival.

Cell Biology↗

Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of alpha-synuclein inclusions

Intracellular inclusions accompanying neurodegeneration are histopathologically and ultrastructurally heterogeneous but the significance of this heterogeneity is unclear. iPSC models, while promising for disease modeling, do not form inclusions in a reasonable timeframe and suffer from limited tractability. Here, we developed an iPSC toolbox utilizing piggyBac-based or targeted transgenes to rapidly induce CNS cells with concomitant expression of aggregation-prone proteins. This system is amenable to screening and longitudinal tracking at single-cell and single-inclusion resolution. For proof-of-principle, cortical neuron -synuclein "inclusionopathy" models were engineered to form inclusions through exogenous seeding or -synuclein mutation. These models recapitulated known fibril- and lipid-rich inclusion subtypes, uncovering dynamic interactions between them, and refined the classification of inclusions in postmortem brain. Genetic-modifier and protein-interaction screens pinpointed proteins like RhoA whose sequestration into specific inclusion subtypes is likely to be toxic. This iPSC platform should enhance our understanding of proteinaceous pathologies in neurodegeneration and facilitate therapeutics development.

neuroscience↗